[Experimental approach to immunotherapy in head and neck malignant tumors--antitumor efficacy by lymphokine activated human peripheral blood lymphocytes].
D000818:Animals; D002460:Cell Line; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000637:transplantation*; D007822:Laryngeal Neoplasms / Q000276:immunology / Q000628:therapy; D008222:Lymphokines / Q000276:immunology*; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000276:immunology / Q000628:therapy; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation
D007376:Interleukin-2; D008222:Lymphokines